Aurinia Pharmaceuticals appoints CEO
Dr. Glickman brings over 30 years of experience in the creation and operation of healthcare ventures, founding and co-founding numerous companies during his career.
Dr. Glickman currently serves as founding Chairman of Essa Pharmaceuticals Inc., Chairman of the Board of Engene Corporation and a Director of Cardiome Pharma. He is also a Partner at Lumira Capital, one of Canada’s most successful healthcare focused venture capital firms.
Dr. Glickman has served on numerous biotechnology and community boards, including member of the federal government’s National Biotechnology Advisory Committee, Director of the Canadian Genetic Disease Network, Chairman of Life Sciences B.C. and a member of the British Columbia Innovation Council.
Dr. Glickman is the recipient of numerous awards including the Ernst and Young Entrepreneur of the Year, a recipient of both BC and Canada’s Top 40 under 40 award, the BC Lifesciences Leadership Award and the Corporate Leadership Award from the Lupus Foundation of America (LFA). ■
LATEST MOVES FROM British Columbia
- Novelion Therapeutics appoints Mark DiPaolo to board
- BTU Capital appoints three executives
- International Wastewater Systems adds Sasko Despotovski to board
- Network Media Group appoints Frank Anderson as director
- DelMar appoints new director, chairman
More inside POST